Penumbra Revenue 2014-2023 | PEN
Penumbra annual/quarterly revenue history and growth rate from 2014 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Penumbra revenue for the quarter ending June 30, 2023 was $0.261B, a 25.51% increase year-over-year.
- Penumbra revenue for the twelve months ending June 30, 2023 was $0.938B, a 16.3% increase year-over-year.
- Penumbra annual revenue for 2022 was $0.847B, a 13.32% increase from 2021.
- Penumbra annual revenue for 2021 was $0.748B, a 33.4% increase from 2020.
- Penumbra annual revenue for 2020 was $0.56B, a 2.38% increase from 2019.
| Penumbra Annual Revenue (Millions of US $) |
|
|---|---|
| 2022 | $847 |
| 2021 | $748 |
| 2020 | $560 |
| 2019 | $547 |
| 2018 | $445 |
| 2017 | $334 |
| 2016 | $263 |
| 2015 | $186 |
| 2014 | $126 |
| 2013 | $89 |
| Penumbra Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2023-06-30 | $261 |
| 2023-03-31 | $241 |
| 2022-12-31 | $221 |
| 2022-09-30 | $214 |
| 2022-06-30 | $208 |
| 2022-03-31 | $204 |
| 2021-12-31 | $204 |
| 2021-09-30 | $190 |
| 2021-06-30 | $184 |
| 2021-03-31 | $169 |
| 2020-12-31 | $167 |
| 2020-09-30 | $151 |
| 2020-06-30 | $105 |
| 2020-03-31 | $137 |
| 2019-12-31 | $145 |
| 2019-09-30 | $140 |
| 2019-06-30 | $134 |
| 2019-03-31 | $128 |
| 2018-12-31 | $121 |
| 2018-09-30 | $112 |
| 2018-06-30 | $110 |
| 2018-03-31 | $103 |
| 2017-12-31 | $96 |
| 2017-09-30 | $84 |
| 2017-06-30 | $81 |
| 2017-03-31 | $73 |
| 2016-12-31 | $73 |
| 2016-09-30 | $67 |
| 2016-06-30 | $65 |
| 2016-03-31 | $58 |
| 2015-12-31 | $54 |
| 2015-09-30 | $50 |
| 2015-06-30 | $42 |
| 2015-03-31 | $39 |
| 2014-12-31 | |
| 2014-09-30 | $32 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $9.172B | $0.847B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $191.350B | 24.00 |
| Intuitive Surgical (ISRG) | United States | $103.656B | 73.93 |
| Edwards Lifesciences (EW) | United States | $42.056B | 27.34 |
| Alcon (ALC) | Switzerland | $36.967B | 32.65 |
| DexCom (DXCM) | United States | $36.673B | 83.67 |
| IDEXX Laboratories (IDXX) | United States | $35.769B | 45.75 |
| IQVIA Holdings (IQV) | United States | $35.499B | 21.26 |
| STERIS (STE) | Ireland | $21.287B | 25.93 |
| Hologic (HOLX) | United States | $16.869B | 17.75 |
| Waters (WAT) | United States | $15.989B | 22.98 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.232B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.511B | 14.81 |
| Sysmex ADR (SSMXY) | Japan | $9.892B | 29.11 |
| Teleflex (TFX) | United States | $9.206B | 14.74 |
| ShockWave Medical (SWAV) | United States | $7.214B | 30.58 |
| Abcam (ABCM) | United Kingdom | $5.188B | 0.00 |
| Globus Medical (GMED) | United States | $4.982B | 22.04 |
| Masimo (MASI) | United States | $4.633B | 23.02 |
| Inari Medical (NARI) | United States | $3.797B | 0.00 |
| Glaukos (GKOS) | United States | $3.459B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $3.094B | 11.69 |
| LivaNova (LIVN) | United Kingdom | $2.837B | 20.25 |
| Elekta AB (EKTAY) | Sweden | $2.635B | 20.82 |
| Integer Holdings (ITGR) | United States | $2.599B | 19.17 |
| Nihon Kohden (NHNKY) | Japan | $2.161B | 17.01 |
| Pacific Biosciences Of California (PACB) | United States | $2.017B | 0.00 |
| TransMedics (TMDX) | United States | $1.721B | 0.00 |
| Veracyte (VCYT) | United States | $1.598B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.514B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.433B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| OPKO Health (OPK) | United States | $1.183B | 0.00 |
| Paragon 28 (FNA) | United States | $0.995B | 0.00 |
| RxSight (RXST) | United States | $0.953B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.946B | 13.54 |
| SiBone (SIBN) | United States | $0.820B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.769B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
| Nevro (NVRO) | United States | $0.698B | 0.00 |
| Artivion (AORT) | United States | $0.625B | 117.08 |
| Silk Road Medical (SILK) | United States | $0.590B | 0.00 |
| IRadimed (IRMD) | United States | $0.555B | 37.97 |
| Mesa Laboratories (MLAB) | United States | $0.541B | 14.97 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.467B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.326B | 33.93 |
| CVRx (CVRX) | United States | $0.312B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.296B | 0.00 |
| Accuray (ARAY) | United States | $0.258B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.249B | 0.00 |
| NeuroPace (NPCE) | United States | $0.234B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.223B | 0.00 |
| AxoGen (AXGN) | United States | $0.215B | 0.00 |
| 908 Devices (MASS) | United States | $0.206B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.176B | 11.40 |
| Sight Sciences (SGHT) | United States | $0.164B | 0.00 |
| Hyperfine (HYPR) | United States | $0.142B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.132B | 0.00 |
| Inogen (INGN) | United States | $0.120B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.118B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.118B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.093B | 0.00 |
| DarioHealth (DRIO) | United States | $0.092B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.090B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.077B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.076B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.066B | 0.00 |
| Vasomedical (VASO) | United States | $0.065B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.063B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.057B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.054B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.046B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.046B | 0.00 |
| Eargo (EAR) | United States | $0.045B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.044B | 19.36 |
| Neuronetics (STIM) | United States | $0.038B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.034B | 0.00 |
| PAVmed (PAVM) | United States | $0.033B | 0.00 |
| Sientra (SIEN) | United States | $0.029B | 0.00 |
| PetVivo Holdings (PETV) | United States | $0.025B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.020B | 0.00 |
| Spectral AI (MDAI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.012B | 0.00 |
| Venus Concept (VERO) | Canada | $0.011B | 0.00 |
| Nemaura Medical (NMRD) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.006B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
